M&A Deal Summary

ULURU Acquires Altrazeal Trading

On May 14, 2015, ULURU acquired life science company Altrazeal Trading for 3M EUR

Acquisition Highlights

This is ULURU’s 1st transaction in the Life Science sector.
This is ULURU’s 0th largest (disclosed) transaction.
This is ULURU’s 1st transaction in Australia.

M&A Deal Summary
Date	2015-05-14
Target	Altrazeal Trading
Sector	Life Science
Buyer(s)	ULURU
Deal Type	Add-on Acquisition
Deal Value	3M EUR

Target

Altrazeal Trading

Vienna, Australia

Altrazeal Trading GmbH is an innovative wound treatment Altrazeal transforming powder dressing.

Search 198,242 Deals Now

SEARCH BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ULURU

Addison, Texas, United States

Category	Company
Sector	Life Science
Employees	7
Revenue	864M USD (2014)

DESCRIPTION

ULURU, Inc. is a pharmaceutical company.

DEAL STATS	#
Overall	1 of 1
Sector (Life Science)	1 of 1
Type (Add-on Acquisition)	1 of 1
Country (Australia)	1 of 1
Year (2015)	1 of 1